| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.001 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |